Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

New blood test for detection of bovine TB

A new blood test to detect Mycobacteria in blood has been developed by a team in Nottingham led by Dr Cath Rees and Dr Ben Swift
  • May 31, 2016
  • Bovine TB

A new blood test to detect Mycobacteria in blood has been developed by a team in Nottingham led by Dr Cath Rees, an expert in microbiology in the School of Biosciences, and Dr Ben Swift from the School of Medical and Veterinary Sciences.

The researchers have used this new method to show that cattle diagnosed with bovine tuberculosis (bTB) have detectable levels of the bacterium Mycobacterium bovis (M. bovis) in their blood which causes this disease.

‘Evidence of Mycobacterium tuberculosis complex bacteraemia in intradermal skin test positive cattle detected using phage-RPA’ has been published online in the peer reviewed medical journal Virulence.

Dr Rees said: “This test delivers results within 48 hours and the frequency in which viable mycobacteria were detected in the blood of skin test positive animals changes the paradigm of this disease.”

This new, simple and inexpensive blood test detects very low levels of mycobacteria in blood using a bacteriophage-based technique developed by The University of Nottingham. The group has patented an improved version of the method that delivers results in just six hours. More recently ‘proof of principal’ experiments have shown that this is even more sensitive. This is currently licenced to a spin out company, PBD Biotech Ltd.

Bovine TB is a zoonotic infectious disease caused by M. bovis. The UK has struggled to eradicate bTB and control measures continue to be a significant economic burden on the agricultural industry.

Routine testing for Bovine TB uses the Single Intradermal Comparative Cervical Tuberculin (SICCT) skin test for M. bovis infection and all healthy cattle are regularly tested this way. However, it is known that this test is only 90% sensitive at best and misses many infected animals.

Dr Cath Rees said: “The data we are getting has taken the scientific community by surprise. In our paper we show that when blood samples from skin test negative cattle were tested for M. bovis cells, all the samples proved negative. However using just a 2ml blood sample, viable Mycobacterium tuberculosis complex bacteria (MTC) were detected in 66% of samples from skin test positive animals. When the carcasses were inspected, it was found that the highest number of bacteria were detected in the animals with visible TB lesions (VL) and 85% of these VL animals were M. bovis positive.

“More excitingly, using our new more sensitive six-hour method, this figure is even higher – all animals with visible lesions were MTC positive, and even 26 out of 28 animals where the lesions were not yet visible also were positive suggesting that M. bovis is commonly found in the circulating blood of infected animals.”

Difficulties in detecting, growing cultures and achieving sensitive detection using the current skin test, which looks for the animal’s an immune response, are a major barrier to understanding and diagnosing bTB infection. Early results indicate that M. bovis can be detected before the animal becomes SCCIT-positive.

Dr Rees said: “Using our bacteriophage-based test the hope is that we can help improve herd control by finding animals at the early stages of infection and helping farmers control outbreaks of bTB more rapidly.”

Working with the United States Department of Agriculture, Agricultural Research Service, National Animal Disease Center, the Nottingham group has set up the first animal trial using the blood test to detect M. bovis in the blood of experimentally infected animals to determine exactly how soon this test can detect infection.

Dr Rees said: “The test also offers the potential for new, better tests for other farm animals. We are directly detecting the bacteria and so the method will work using blood samples from any animal species – so far we have detected mycobacteria in the blood of cattle, sheep and horses, but it could also be used for deer, goats or llamas. “Not only that, we can detect any type of mycobacteria, we have use the same method to detect other diseases, such as Johne’s disease, not just bTB.”

Share:

Related posts

Loading...

Which is the best test for bovine TB?

October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective tools to help prevent and manage the disease

Which is the best test for bovine TB?

October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective...
Johne's Disease testing service

Heartbreak and hope – the story of a new diagnostic for bovine TB

June 30, 2021
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache at an Agri-TechE hosted webinar.
Johne's Disease testing service

Heartbreak and hope – the story of a new diagnostic for bovine TB

June 30, 2021
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache...
David Christensen

Actiphage to offer greater decision support in the fight against Bovine TB

May 14, 2021
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK, and we don’t appear to be getting on top of it. We need many more tools in the toolbox in...
David Christensen

Actiphage to offer greater decision support in the fight against Bovine TB

May 14, 2021
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK,...
Cow on Lammas Land Bovine TB eradication

BVA advocates One Health approach to Bovine TB eradication

August 4, 2020
Allowing farmers with Official Tuberculosis Free (OTF) status to use APHA approved but currently un-validated tests for Bovine TB (bTB) is one of the recommendations of the British Veterinary Association (BVA) in its recent policy statement. PBD Biotech, developers of...
Cow on Lammas Land Bovine TB eradication

BVA advocates One Health approach to Bovine TB eradication

August 4, 2020
Allowing farmers with Official Tuberculosis Free (OTF) status to use APHA approved but currently un-validated tests for Bovine TB (bTB)...
1 2 … 5 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More